The specific identification of a different set of miRNAs (all downregulated) in KRAS mutated CRC tissues respect to wild type CRC tissues could suggest their putative role as responsive molecular targets (i.e., by ectopically modifying their expression levels). The gene discussed is KRAS; the disease is colorectal carcinoma.